{"task_id": "d6ce092707daddfe", "source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 172/464)", "text": "ncertain\n160\nApproach to Anticoagulation Therapies\n\n--- Page 182 ---\nClass/Drugs\nMechanism\nIndications\nUsual dose\nComplications/\nmonitoring\nFondaparinux\nIndirect factor Xa inhibitor\n(highly selective).\nSimilar to LMWH, but only a\npentasaccharide that binds\nstrongly to AT and\ninactivates factor Xa.\nComplex does not bind\nthrombin due to short\nlength\nDVT prophylaxis\nAcute DVT/PE\nAcute coronary\nsyndrome\nHITT (no cross\nreactivity\nwith heparin\ndependent\nanti platelet\nantibodies)\nFor DVT prophylaxis,\nfondaparinux 2.5 mg SC\ndaily (start 6\u20138 h after\nsurgical hemostasis)\nFor acute clots,\nfondaparinux 5 mg SC\ndaily for weight < 50 kg,\n7.5 mg SC daily for weight\n50\u2013100 kg, 10 mg SC\ndaily for weight >100 kg\nFor UA/NSTEMI,\nfondaparinux 2.5 mg SC\ndaily \u00038 days or until\ndischarge\nFor STEMI, fondaparinux\n2.5 mg IV \u00031 then 2.5 mg\nSC daily \u00038 days or until\ndischarge\nComplications\u2014bleeding;\navoid in spinal surgery\nMonitor\u2014antifactor Xa\nactivity\nRivaroxaban\nDirect factor Xa inhibitors\n(highly selective).\nSimilar to fondaparinux,\nbut specifically inhibits\nfactor Xa by binding to its\nactive site without\ninteracting with AT\nDVT prophylaxis\n(phase II)\nComplications\u2014bleeding\nMonitor\u2014antifactor Xa\nactivity\nDirect\nthrombin\ninhibitors:\nDabigatran\nDesirudin\nLepirudin\nArgatroban\nXimelagatran\nDirect thrombin inhibitors\n(highly selective). AT\nindependent. In contrast\nto heparin, LMWH, and\nheparinoid, direct\nthrombin inhibitors can\ninhibit clot bound\nthrombin because their\nsites for binding (active\nsite \u0004 exosite I) are not\nmasked by fibrin.\nDoes not depend on AT for\naction and thus unaffected\nby AT deficiency\nHITT (lepirudin,\nargatroban)\nACS (hirudin,\nargatroban)\nDVT prophylaxis\n(hirudin,\ndabigatran)\nFor HITT, lepirudin\n0.1\u20130.4 mg/kg IV bolus,\nthen 0.1\u20130.15 mg/kg/h;\nargatroban 2 mg/kg/min\ninfusion\nComplications\u2014bleeding\nMonitor\u2014aPTT\nCONTRAINDICATIONS TO WARFARIN THERAPY\nABSOLUTE\nneurosurgery, ocular surgery or intra\ncranial bleeding within the past 10 days, active\nbleeding, severe bleeding diathesis, or platelet\n<20\u0003103/mL\nRELATIVE\nmild to moderate bleeding diathesis or\nthrombocytopenia (20 100\u0003103/mL), brain metas\ntases, recent major trauma, major abdominal surgery\n<2 days, GI or GU bleeding <2 weeks, endocarditis,\nsevere hypertension (>200/120 mmHg)\nRelated Topics\nDVT (p. 158)\nHypercoagulable States (p. 156)\nPulmonary Embolism (p. 8)\nWARFARIN INDUCED SKIN NECROSIS\nCLINICAL FEATURES\nusually within first few days\nof warfarin therapy (especially large loading doses)!\nsignificantly decreases protein C levels ! transient\nhypercoagulable ! erythematous macule ! purpu\nric zone ! necrotic lesion. Occurs over extremities,\nbreast, trunk, and penis\nTREATMENTS\nimmediately stop warfarin, give\nvitamin K, heparin IV, consider FFP or protein C con\ncentrate. Lesion may continue to progress despite\nadequate anticoagulation\nCORRECTION OF SUPRATHERAPEUTIC INR DUE TO\nWARFARIN USE\nINR <5\nif no significant bleeding, rapid reversal is\nnot indicated. Reduce warfarin dose or hold the next\nwarfarin dose\nApproach to Anticoagulation Therapies (cont\u2019d)\nApproach to Anticoagulation Therapies\n161", "text_length": 3089, "metadata": {"source": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf (Part 172/464)", "type": "chunk", "chunk_index": 171, "total_chunks": 464, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T18:40:09.482312", "document_uuid": "fda2cab4-cdd9-4015-af24-46fd62c86d94", "filename": "Approach to Internal Medicine_ A Resource Book for Clinical Practice ( PDFDrive ).pdf", "category": "medical_pdf", "section": "body", "year": null, "outdated": false, "document_id": "fda2cab4-cdd9-4015-af24-46fd62c86d94"}, "created_at": "2025-12-11T18:40:09.483071", "status": "complete", "chunks_added": 2}